EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totaling 5,098 shares, a growth of 60.8% from the March 31st total of 3,171 shares. Based on an average daily volume of 227,247 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company's shares are sold short.
EssilorLuxottica Trading Down 0.4%
ESLOY stock traded down $0.39 during mid-day trading on Monday, reaching $108.76. The company had a trading volume of 231,596 shares, compared to its average volume of 122,005. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70. The firm has a 50 day moving average of $121.83 and a 200 day moving average of $151.61. EssilorLuxottica has a 12 month low of $108.37 and a 12 month high of $186.81.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on ESLOY. HSBC raised shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research report on Wednesday, January 14th. Kepler Capital Markets raised shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research report on Thursday, January 15th. Two equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Buy".
Check Out Our Latest Stock Analysis on EssilorLuxottica
EssilorLuxottica Company Profile
(
Get Free Report)
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EssilorLuxottica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.
While EssilorLuxottica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.